Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Therapies in ALS - beyond Riluzole
Karen Morrison
Research output
:
Contribution to journal
›
Article
27
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Therapies in ALS - beyond Riluzole'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Motor Neuron Disease
100%
Riluzole
100%
Cell Culture
50%
High-throughput
50%
Glutamate
50%
Amyotrophic Lateral Sclerosis
50%
Hypoxia Response
50%
Neurotoxicity
50%
Oxidative Stress
50%
Screening System
50%
Mitochondrial Abnormalities
50%
Stem Cell Therapy
50%
Neurofilament
50%
Neuroscience
Amyotrophic Lateral Sclerosis
100%
Riluzole
100%
Stem Cell
50%
Glutamic Acid
50%
Excitotoxicity
50%
Neurofilament
50%
Oxidative Stress
50%
Cell Culture
50%
Cell Therapy
50%
Biochemistry, Genetics and Molecular Biology
Motor Neuron
100%
Riluzole
100%
Cell Culture
50%
Neurofilament
50%
Oxidative Stress
50%
Excitotoxicity
50%
Glutamic Acid
50%
Stem Cell Transplantation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Amyotrophic Lateral Sclerosis
100%
Riluzole
100%
Hypoxia
50%
Glutamic Acid
50%
Excitotoxicity
50%
Cell Culture
50%